Before diving deeper into the specifics of the Plex-Ginkgo partnership, it’s vital to understand how AI is reshaping the drug discovery process: The collaboration between Plex and Ginkgo ...

Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...

CAMBRIDGE, Mass., April 03, 2025--(BUSINESS WIRE)--Plex Research, a biotechnology company using autonomous artificial intelligence (AI) to aid in drug discovery, today announced that it is ...

Iwaoka began with a brief background of the Mahol-A-Ba platform, which, she explained, established a “Human-in-the-Loop” drug discovery process that integrates humans, AI, and robots.

Artificial intelligence (AI) in drug discovery is moving beyond the proof-of-concept stage. Advanced machine learning (ML) techniques are powering technologies that slash the time needed to value ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital ...

While these transformational approaches are still in the early stages, it’s clear that applying AI and accelerated computing to drug discovery will have a multiplying impact on the efficiency ...

There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector. The drug discovery space is no different, with myriad ...